• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Severance package


<



Just that any of us with 10 plus years will be fine. Nice 60 day Warn, bonus checks and unused vacation. Don’t over think this process. You will not know who until the call.
 




Similar threads

Replies
63
Views
31K
Replies
7
Views
3K
Replies
11
Views
3K
Replies
19
Views
5K